Clinical trial
Immune Mechanisms During SAPHO Syndrome and Treatment by Etarnecept
NCT01688219 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immune Mechanisms During SAPHO Syndrome and Treatment by Etarnecept
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2005
- Completion date
- May 31, 2008
- Enrollment
- 39 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
sapho syndrome